Round 2 of the Techno-Blast
 
 
ATMI
The Source of BioProcess Efficiency
 
SAFC
SAFC Partnership with
Sartorius Stedim
 
Sartorius Stedim
Turning Science Into Solutions
 
Pall
Filtration, Separation,
and Purification Solutions
 
NBSC
A Culture of Innovation
 
Career Development
Training-Networking-Jobs
 

 

We will do our best to post announcements for the most valuable training courses, networking opportunities, and job openings. Please help us build this portion of the site by sending us your event and job postings.
 

ECI

Vaccine Technology III
Call for Abstracts


CfPie

Sterilization Procedures:
Technology, Equipment and Validation


Bioassays 2009:
Scientific Approaches & Regulatory Strategies

CASS

New Two-Day Conference


FDA_Logo

Jobs at the Center for Biologics Evaluation and Research (CBER)


Featured Suppliers


Saint Gobain

High-Performance Platinum-Cured
Silicone Tubing: The Next Generation


Doe$Ingalls

WEBCAST: How to Systematically Assess Raw Material Risk


SCBT_logo

Free Antibody Promotion

 

 

 
 

 

Authentication and Characterization of Animal Cell Lines:
The Impact on Research

By Yvonne A. Reid, PhD (yreid@atcc.org), Collection/Research Scientist, Cell Biology Program; ATCC, Manassas, Virginia.


Applying Modern Design of Experiments to Mass Transfer Characterization in Bioreactors

By Priyal Sheth, associate bioprocess engineer; and Semsi Ensari, PhD, (semsi.ensari@Ambrx.com) senior bioprocess engineer; Ambrx, Inc., La Jolla, California.


Sponsored Link

A leader in single-use mixing, storage and
bioreactor technology, ATMI LifeSciences
doubles its manufacturing capacity:

With upgrades and modifications to its North American manufacturing facility in Bloomington, Minnesota, ATMI LifeSciences is responding to growing U.S. demand for disposable bioprocess vessels while doubling its worldwide production capacity. The site has added a Grade B clean room for fabricating complex three-dimensional storage, mixing and bioreactor vessels, and has created an on-site quality testing laboratory to analyze and manage sterility levels in the manufacturing environment. In addition, the company continues to manufacture bioprocess vessels at its facility in Belgium. The time-frame for shipping commercial products from the North American facility is expected to be in 2010.

Using fluoropolymer-based products and custom-engineered, flexible packaging solutions, ATMI LifeSciences is a leader in single-use mixing, storage, and bioreactor technology. The company’s fundamental knowledge of polymers, specially selected resins, and clean room manufacturing technology combine to produce the highest quality products for critical process operations. For more information, please visit www.atmi-lifesciences.com or contact Jeff Craig, ATMI LifeSciences, Global Director, Life Sciences Marketing and Business Development at JCraig@atmi.com.  

 
News from FDA

Public Advisory Committee Meeting Regarding the Potential Licensing of a Cell Therapy: October 9, 2009


Public Workshop On How To Do Better Cancer
Vaccine Clinical Trials: October 27, 2009


Two NEW Guidance Documents: Cancer Vaccines
and Pancreatic Islet Transplants
 
Your Contributions

SUBMISSIONS:

Please submit materials via email to the-techie@biotechnoblog.net, but be sure to zip the file if it exceeds 2 MB.  Another option is to mail us the file on a key drive, but note that we won’t return your drive since we collect them and it isn’t worth the handling cost.  And then you can upload the file to your FTP site and send us the URL and password we’ll need to download it.  Or you can simply email us a link so we can view the material on another website.  Depending on the content and format of the material, we will post links to wherever it can best be viewed or downloaded.   

All submissions must address a recent advancement or solidify a “best practice” for biologic product development or production. The material format can be streaming video, YouTube postings, automated PowerPoint presentations; as well as PDF, HTML, Word and Excel docs. Be sure to include complete contact information for the corresponding submitter, an introduction of no more than 75 words, and a list of key words.

REVIEWERS:

If you would like to help review submissions for a specific application or technology area, please contact the-boss@biotechnoblog.net. Include your full contact information, the area(s) in which you would like to contribute, and any relevant experience you’ve had on a review or advisory board.

ADVERTISING AND SPONSORSHIPS:

Please contact the-closer@biotechnoblog.net to get a quote for advertising or for sponsoring our efforts.

CONTACT US:

We hope you enjoy visiting our site and find the content both valuable and timely. We are committed to posting the best technical content we can collect as we do our best to make your interaction a pleasurable experience. We look forward to reading your comments at the-boss@biotechnoblog.net.

 
 
 

To view prior Techno-Blasts,
go to our archives.

Headlines and links will take you to various postings on our site, and when appropriate, to the sites of various contributors. Postings will include articles, presentations, assays, techniques, protocols, blog chat, reviewer comments, product tutorials, virtual tours, application data, and pretty much any other form of online material that’s needed to develop and produce safe and effective products.

 
Applications

Our initial focus will be on the toughest applications which tend to receive very little coverage elsewhere, such as viral gene vectors and cellular products. But as things progress and interest is expressed, we’ll be adding Development Groups to cover applications such as vaccines, antibodies, recombinant proteins, and tissue regeneration.

Each technology and application will have its own Development Group with one or more Reviewers and numerous contributors.

 
Development Groups
  • Viral Vectors
  • Cellular Products
  • Safety and Efficacy
  • Cell Banking
  • Vaccines
  • Antibodies and Recombinant
    Proteins
  • Facilities
  • Quality Systems
Technologies
 
Technologies will include essentially all the unit operations and support functions involved in bioprocessing, such as cell engineering and banking, cell culture scale-up, filtration, purification, media development, assay development, regulatory affairs, and facility design.
 
Format
 
Content formats will include streaming video, YouTube postings, automated PowerPoint presentations; and of course PDF, HTML, Word, and Excel docs.
 
SUPPLIER TECHNOLOGY:

We will be posting valuable information from key technology supply firms. As with our other primary content, these postings will have been assessed for their balance and credibility, and will include application data, tutorials, articles, presentations, and case histories.

Then in our Supplier-Side column, we will post materials with clear commercial content such as infomercials, ads, press releases and promotions. And while some of these will be sponsored postings, other valuable resources will appear with no strings attached.